Winton Group LTD Fulgent Genetics, Inc. Transaction History

Winton Group LTD

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$28.52 - $40.7 $419,129 - $598,127	-14,696 Reduced 68.93%	6,624 $245,000
Q1 2023 May 12, 2023	BUY	$29.39 - $36.27 $242,908 - $299,771	8,265 Added 63.31%	21,320 $665,000
Q4 2022 Feb 14, 2023	SELL	$29.23 - $40.28 $136,884 - $188,631	-4,683 Reduced 26.4%	13,055 $388,000
Q3 2022 Nov 10, 2022	SELL	$37.92 - $63.74 $1.41 Million - $2.36 Million	-37,087 Reduced 67.65%	17,738 $676,000
Q2 2022 Aug 10, 2022	SELL	$47.98 - $62.75 $367,622 - $480,790	-7,662 Reduced 12.26%	54,825 $2.99 Million
Q1 2022 May 11, 2022	BUY	$49.85 - $96.11 $2.6 Million - $5.02 Million	52,195 Added 507.14%	62,487 $3.9 Million
Q4 2021 Feb 10, 2022	SELL	$77.3 - $105.0 $2,473 - $3,360	-32 Reduced 0.31%	10,292 $1.04 Million
Q3 2021 Oct 28, 2021	BUY	$74.87 - $110.87 $512,335 - $758,683	6,843 Added 196.58%	10,324 $929,000
Q2 2021 Aug 10, 2021	BUY	$66.8 - $100.45 $232,530 - $349,666	3,481 New	3,481 $321,000

201

16.1M

2.04M

14K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $609M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

Stay updated on Winton Group LTD with notifications on news.